A novel cuproptosis-related gene signature for the prediction of liver cancer prognosis identified DLAT is a potential therapeutic target
Dong Xu, Fei Yang, Yang Chen, Hong Zhu, Haijian Sun, Tong Shen, Yongkang Zhu, Guowei Zhou, Dexuan Chen, Xiaojun Yang, Kai Lin, Cunbing Xia
doi: https://doi.org/10.1101/2022.10.23.22280648
Dong Xu
1Department of General Surgery, Gaochun People’s Hospital, Nanjing, Jiangsu, China
Fei Yang
2Department of Internal Medicine, Gaochun People’s Hospital, Nanjing, Jiangsu, China
Yang Chen
3Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
Hong Zhu
4Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China
Haijian Sun
4Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China
Tong Shen
4Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China
Yongkang Zhu
4Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China
Guowei Zhou
4Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China
Dexuan Chen
4Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China
Xiaojun Yang
5Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Kai Lin
6Nanjing Medical University, Nanjing, Jiangsu, China
Cunbing Xia
4Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China

- Additional file 1[supplements/280648_file17.xlsx]
- Additional file 2[supplements/280648_file18.xlsx]
Posted October 25, 2022.
A novel cuproptosis-related gene signature for the prediction of liver cancer prognosis identified DLAT is a potential therapeutic target
Dong Xu, Fei Yang, Yang Chen, Hong Zhu, Haijian Sun, Tong Shen, Yongkang Zhu, Guowei Zhou, Dexuan Chen, Xiaojun Yang, Kai Lin, Cunbing Xia
medRxiv 2022.10.23.22280648; doi: https://doi.org/10.1101/2022.10.23.22280648
A novel cuproptosis-related gene signature for the prediction of liver cancer prognosis identified DLAT is a potential therapeutic target
Dong Xu, Fei Yang, Yang Chen, Hong Zhu, Haijian Sun, Tong Shen, Yongkang Zhu, Guowei Zhou, Dexuan Chen, Xiaojun Yang, Kai Lin, Cunbing Xia
medRxiv 2022.10.23.22280648; doi: https://doi.org/10.1101/2022.10.23.22280648
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)